Cargando…
Efficacy of the current investigational drugs for the treatment of COVID-19: a scoping review
To date, there is no final FDA-approved treatment for COVID-19. There are thousands of studies published on the available treatments for COVID-19 virus in the past year. Therefore, it is crucial to synthesize and summarize the evidence from published studies on the safety and efficacy of experimenta...
Autores principales: | Wadaa-Allah, Ahmed, Emhamed, Marwa S., Sadeq, Mohammed A., Ben Hadj Dahman, Nesrine, Ullah, Irfan, Farrag, Nesrine S., Negida, Ahmed |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7971293/ https://www.ncbi.nlm.nih.gov/pubmed/33706639 http://dx.doi.org/10.1080/07853890.2021.1875500 |
Ejemplares similares
-
Correlation between COVID-19 case fatality rate and percentage of BCG vaccination: is it true the vaccine is protective?
por: Mohamed Hussein, Aliae A. R., et al.
Publicado: (2020) -
The role of angiotensin-converting enzyme 2 (ACE2) genetic variations in COVID-19 infection: a literature review
por: Fawzy, Manal S., et al.
Publicado: (2022) -
Liver injury with COVID-19: laboratory and histopathological outcome—systematic review and meta-analysis
por: Mohammed, Sherine A., et al.
Publicado: (2022) -
Characteristics of the clinical and global neurosurgical research publications from Africa: A scoping review
por: Moawad, Mostafa Hossam El din, et al.
Publicado: (2023) -
Prognosis of COVID-19 in respiratory allergy: a systematic review and meta-analysis
por: El Shahawy, Alia Abdelmonem, et al.
Publicado: (2022)